Semler Scientific (NASDAQ:SMLR - Get Free Report) posted its earnings results on Tuesday. The company reported $3.41 earnings per share for the quarter, topping analysts' consensus estimates of $0.20 by $3.21, Zacks reports. The firm had revenue of $12.41 million for the quarter. Semler Scientific had a net margin of 72.65% and a return on equity of 50.77%.
Semler Scientific Stock Down 8.6 %
NASDAQ:SMLR traded down $4.50 on Friday, hitting $47.74. The stock had a trading volume of 282,980 shares, compared to its average volume of 419,604. Semler Scientific has a 52 week low of $20.88 and a 52 week high of $81.56. The business's fifty day moving average is $56.42 and its 200 day moving average is $42.72. The company has a market cap of $442.55 million, a PE ratio of 9.72 and a beta of 1.17.
Wall Street Analysts Forecast Growth
Separately, Lake Street Capital raised their target price on Semler Scientific from $40.00 to $71.00 and gave the stock a "buy" rating in a research report on Friday, January 24th.
Get Our Latest Stock Report on SMLR
Semler Scientific Company Profile
(
Get Free Report)
Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.
Featured Articles

Before you consider Semler Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Semler Scientific wasn't on the list.
While Semler Scientific currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.